FDA has granted priority review status to Merck's application to expand marketing of its human papillomavirus vaccine Gardasil to women ages 27 to 45, the company said Wednesday, Reuters reports. The designation means that an FDA decision could come within six months, according … [Read more...] about FDA To Review Merck’s Application To Expand HPV Vaccine Gardasil’s Approval To Older Women